DB18660ApprovedWithdrawnCell transplant therapies
Holoclar (ex vivo expanded autologous human corneal epithelial cells containing stem cells) is a stem cell therapy used to treat limbal stem cell deficiencies.
- First approval
- European Union, 2016
- Brand names
What you can answer from here — as of April 02, 2025
Which companies are running trials of Ex vivo expanded autologous human corneal epithelial cells containing stem cells, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account